Affiliation: Jikei University School of Medicine
Furukawa K, Iida T, Shiba H, Fujiwara Y, Uwagawa T, Shimada Y, et al
. Anti-tumor effect by inhibition of NF-kappaB activation using nafamostat mesilate for pancreatic cancer in a mouse model. Oncol Rep. 2010;24:843-50 pubmed
..These results suggested that nafamostat mesilate has anti-neoplastic property against experimental pancreatic cancer. ..
Furukawa K, Uwagawa T, Iwase R, Haruki K, Fujiwara Y, Gocho T, et al
. Prognostic factors of unresectable pancreatic cancer treated with nafamostat mesilate combined with gemcitabine chemotherapy. Anticancer Res. 2012;32:5121-6 pubmed
Furukawa K, Uwagawa T, Sakamoto T, Shiba H, Tsutsumi J, Yanaga K. Curative Resection After Gemcitabine, Cisplatin and S-1 Chemotherapy for Initially Unresectable Biliary Duct Cancer: A Case Report. Anticancer Res. 2015;35:4203-6 pubmed
..The pathological stage was pT1N0M0, stage I. The patient made a satisfactory recovery, was discharged 29 days after operation, and remains free of disease at 3 months after the operation under adjuvant chemotherapy using S-1. ..
Furukawa K, Shiba H, Shirai Y, Horiuchi T, Iwase R, Haruki K, et al
. Negative Impact of Preoperative Endoscopic Biliary Drainage on Prognosis of Pancreatic Ductal Adenocarcinoma After Pancreaticoduodenectomy. Anticancer Res. 2015;35:5079-83 pubmed
..0447) and microscopic or macroscopic residual tumor (p=0.0184) were independent factors for poor overall survival. Preoperative EBD may have a negative impact on prognosis after PD for pancreatic ductal adenocarcinoma. ..
Furukawa K, Yoshida K, Nojiri T, Ogawa M, Kohno S, Yanaga K. Adult intussusception caused by Meckel's diverticulum complicated by anisakiasis of the small intestine: report of a case. Clin J Gastroenterol. 2014;7:316-9 pubmed publisher
..On pathology, the anisakis body was found in the resected specimen of the ileum with wall thickness. The patient was discharged 8 days after surgery. ..
Furukawa K, Iida T, Shiba H, Akita H, Sasaki M, Yanaga K. Nontraumatic intramural hematoma of the duodenum. Clin J Gastroenterol. 2010;3:22-4 pubmed publisher
..The cause was considered to be bleeding tendency caused by an antiplatelet drug. The patient was treated conservatively and the size of the hematoma was followed on CT. She was able to resume oral feeding 2Â weeks after admission. ..
Furukawa K, Ohashi T, Haruki K, Fujiwara Y, Iida T, Shiba H, et al
. Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-?B inhibitor for pancreatic cancer in mice. Cancer Lett. 2011;306:92-8 pubmed publisher
..05). In conclusion, adenovirus vector-mediated TNF-? gene therapy combined with nafamostat mesilate was effective for pancreatic cancer in mice. ..
Furukawa K, Uwagawa T, Haruki K, Fujiwara Y, Iida T, Shiba H, et al
. Nuclear factor ?B activity correlates with the progression and prognosis of pancreatic cancer in a mouse model. Surg Today. 2013;43:171-7 pubmed publisher
..001) resulting in worse survival in vivo (p = 0.0339). These results suggested that NF-?B activity is related to expression of its downstream target genes, tumor progression and prognosis in experimental pancreatic cancer model. ..